Immunologie, Oncologie
|
Thérapie cellulaire
August 28, 2026
George Demetri, MD and Charles Saywers, MD, members of CellCarta's Scientific Advisory Board, join Christopher Ung, our Chief Scientific Business Officer, for a conversation on advancements in immunotherapies, treating solid tumors, and what's next for the field.
